This content has not yet been reviewed and may contain errors.

approach to proteinuria and haematuria

in review 5 min read Updated 2026-08-27
approach to proteinuria and haematuria

Proteinuria and haematuria are urinary markers of kidney disease that may present alone or together. The combination — particularly dysmorphic haematuria with proteinuria — strongly suggests glomerular pathology and warrants urgent nephrology input. Isolated proteinuria drives CKD staging and renoprotection decisions. Isolated haematuria requires distinguishing glomerular from urological causes.

do not miss
  • nephritic syndrome (haematuria + proteinuria + AKI + hypertension) → RPGN workup same day; delay costs nephrons
  • visible haematuria in adults ≥35–40 → exclude urological malignancy (cystoscopy + upper-tract imaging)
  • nephrotic-range proteinuria (UPCR >350 mg/mmol) with hypoalbuminaemia → thrombotic risk, urgent nephrology — see nephrotic syndrome
  • pulmonary-renal syndrome — haemoptysis + haematuria + AKI → anti-GBM or ANCA vasculitis; nephrology and ICU same day

proteinuria

quantification

methodmeasurenotes
urine dipsticksemiquantitative (trace to 4+)detects albumin only; misses light chains, tubular proteins. Affected by urine concentration — always confirm
urine ACR (mg/mmol)albumin-specificpreferred screening and CKD staging (KDIGO). First-morning sample best
urine PCR / UPCR (mg/mmol)total proteindetects non-albumin proteins (light chains, tubular). Use when myeloma or tubulointerstitial disease suspected
24 h urinegold standardrarely needed — spot ACR or UPCR with first-morning void is adequate for most decisions
ACR vs UPCR

ACR is the standard for CKD screening and staging. UPCR is better when non-albumin proteinuria matters — overflow (myeloma light chains) or tubular proteinuria. If dipstick is negative but renal disease is suspected, request UPCR.

classification by severity (KDIGO)

ACR (mg/mmol)categoryclinical implication
<3A1 — normalno action
3–30A2 — moderateCKD if persistent ≥3 months; start RAS blockade; consider SGLT2 inhibitors if ACR ≥20
>30A3 — severehigh-risk CKD; RAS blockade + SGLT2 inhibitors; nephrology referral
UPCR ≥50 (~0.5 g/day)biopsy thresholdconsider renal biopsy, especially if glomerular features (KDIGO 2025 IgAN)
UPCR >350 (~3.5 g/day)nephrotic-rangesee nephrotic syndrome

Confirm persistence — repeat ACR on two of three first-morning samples over 3 months before labelling CKD.

transient / benign causes to exclude first

Fever, exercise, UTI, menstruation, dehydration, heart failure exacerbation. Orthostatic proteinuria in patients <30 yr (first-morning ACR normal, upright elevated) — benign, no follow-up.

If dipstick-positive, exclude transient causes → quantify with ACR + UPCR → manage per severity table above. UPCR elevated with normal ACR → consider overflow proteinuria (SPEP/UPEP, free light chains) or tubular proteinuria.


haematuria

confirm and classify

  • Dipstick positive for blood → microscopy to confirm true haematuria (≥3 RBCs per HPF). Dipstick detects haem — false positives with myoglobinuria, haemoglobinuria.
  • Visible (macroscopic) vs non-visible (microscopic) — different workup urgency.

glomerular vs non-glomerular

featureglomerularurological
RBC morphologydysmorphic, acanthocytes ≥5%isomorphic
castsRBC casts (pathognomonic)absent
clotsabsentmay be present
colourbrown / “cola” / “tea”red / pink
proteinuriaoften presentusually absent
painusually painlessmay have flank/suprapubic pain
RBC casts = glomerulonephritis

RBC casts on urine microscopy are pathognomonic for glomerular bleeding and warrant urgent nephrology referral — do not wait for serologies. Acanthocytes ≥5% are also highly specific for glomerular origin.

haematuria workup

Glomerular haematuria (dysmorphic RBCs, RBC casts, or concurrent proteinuria):

  • Nephrology referral
  • Serologies: ANA, ANCA, anti-GBM, C3/C4, ASO/anti-DNase B, hepatitis B/C, HIV
  • SPEP/UPEP, free light chains if >40 yr
  • Renal biopsy — guided by clinical context; IgA nephropathy is the most common cause of glomerular haematuria worldwide

Non-glomerular / urological haematuria (isomorphic RBCs, no casts, no significant proteinuria):

  • Visible haematuria → cystoscopy + CT urogram (preferred upper-tract imaging for gross bleeding)
  • Non-visible + risk factors (age ≥35–40, smoking, occupational exposures) → cystoscopy + renal ultrasound (CUA approach); reserve CT urogram for US-positive or higher-risk patients. Uniform CT for all microhaematuria increases radiation-induced cancers and cost for marginal detection gain
  • Non-visible, low-risk (age <35, no risk factors, single episode) → repeat urinalysis in 6 months; if persistent, image

Risk factors for urological malignancy: age ≥35–40, smoking history, occupational carcinogen exposure (aromatic amines — dyes, rubber, plastics), prior pelvic radiation, cyclophosphamide exposure, chronic catheterisation.


combined haematuria and proteinuria

The combination narrows the differential to glomerular disease in most cases:

patternthinknext step
haematuria + sub-nephrotic proteinuriaIgA nephropathy, thin basement membrane disease, Alport syndrome, lupus nephritisnephrology referral → likely biopsy
haematuria + nephrotic-range proteinuriamembranous with nephritic features, lupus class III–V, MPGNurgent nephrology
haematuria + AKI + hypertensionRPGN — anti-GBM, ANCA vasculitis, lupus, IgA with crescentssame-day nephrology; serologies + biopsy urgently
episodic visible haematuria with URTIsIgA nephropathy (synpharyngitic haematuria)nephrology referral; biopsy if proteinuria or declining eGFR

referral

Nephrology — persistent ACR >30 (A3), any glomerular haematuria, haematuria + proteinuria, acute kidney injury with active sediment, suspected RPGN (same day).

Urology — visible haematuria without glomerular features, non-visible haematuria with malignancy risk factors (age ≥35–40, smoking), structural abnormality on imaging.


traps

  • Dipstick protein misses non-albumin proteins — a negative dipstick does not exclude myeloma-related proteinuria. Request UPCR or free light chains if clinical suspicion exists.
  • Attributing haematuria to anticoagulation — anticoagulants do not cause haematuria; they unmask existing pathology. Always investigate.
  • Ignoring isolated microscopic haematuria in young patients — if dysmorphic or with proteinuria, this may be early IgA nephropathy or Alport syndrome. Repeat urinalysis and check ACR.
  • Overcalling dipstick haematuria — myoglobinuria (rhabdomyolysis) and haemoglobinuria (haemolysis) trigger the dipstick. Microscopy confirms true haematuria.
  • Dismissing transient proteinuria without follow-up — repeat at 3 months. Persistent A2+ proteinuria changes CKD staging and management.

Key references

+4 more sources

Suggest a correction approach to proteinuria and haematuria